Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)
- Citation:
- Oncologist vol 28 (8) 722-9
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3723
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- UG1CA189823, UG1CA190140, UG1CA232760, UG1CA233163
- Corr. Author:
- Authors:
- Rudolph M Navari Jennifer Le-Rademacher Fabrice Smieliauskas Kathryn J Ruddy Thomas James Saphner Heshan Liu Elizabeth Harlos Adedayo A Onitilo Karthik Giridhar Preet Paul Singh Pavan S Reddy Selina Chow Flavio Kruter George Raptis Charles L Loprinzi
- Networks:
- KS055, LAPS-AL002, LAPS-MN026, MD020, MI020, NORTHWELL, WINCORP
- Study
- Alliance-A221602
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: